Article
Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
Virology - 1 Jul 2024
Lee Joseph, Naoe Youichi, Bang Uikyu, Nakagama Yu, Saito Akatsuki, Kido Yasutoshi, Hotta Akitsu
Abstract excerpt
Two SARS-CoV-2 XBB sub-variants, FL.1 and GE.1, have been increasing in prevalence worldwide, but limited information is available about their ability to evade the immune system. FL.1 and GE.1 are emerging Omicron XBB variants possessing additional mutations in the spike RBD raising concerns of increased neutralization escape. In this study, we assessed the neutralizing ability of eleven FDA-approved monoclonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.